Markets
Researchers Propose Shielded Bitcoin for Zcash-Style Privacy Without Soft Fork
A new protocol could enable private Bitcoin transactions using encrypted notes and zero-knowledge proofs, bypassing the need for a base-layer consensus change.
Bitget Loses $351M in Hack via Spoofed Transfers, Not Private Key Theft
Crypto exchange Bitget said attackers faked transfer requests to drain $351.6 million without compromising private keys; a $464 million protection fund covers the loss.
Shearwater Group Plans Shareholder Vote on £19.9M Capital Reduction
The company seeks shareholder approval for a special resolution to cancel deferred shares and amend articles, requiring 75% support and court confirmation before implementation.
Gold heads for weekly loss on dollar strength, Fed rate outlook
Spot gold fell 2% for the week to around $4,288 as a stronger dollar and hawkish Federal Reserve commentary weighed on prices.
Sixth Circuit Rules Kalshi Sports Contracts Fall Under State, Not Federal, Regulation
The Sixth Circuit joined the Eighth in finding Kalshi's sports-event contracts are not swaps, deepening a circuit split headed for the Supreme Court.
KelpDAO lawsuit accuses LayerZero of failing to secure $292M rsETH bridge exploit
Dispute over cross-chain security escalates as LayerZero denies wrongdoing in DeFi bridge attack
Dollar strength persists as bond yields lift GBP/USD
Sterling’s gains stall as US Treasury yields rise and energy markets sustain dollar support, despite resilient eurozone data offsetting eurozone spreads.
Fate Therapeutics Secures $15M CIRM Grant for Lupus Nephritis Trial
California Institute for Regenerative Medicine awards $15 million to support Phase 2 study of FT819 in refractory lupus nephritis patients.
OG.com seeks CFTC approval for cash-settled single-stock perpetual futures
The crypto‑derived platform filed a request to list 24‑hour, cash‑settled perpetual contracts on individual US equities, joining other firms such as Coinbase and Kalshi in seeking regulatory clearance.
Ex-CFTC Commissioner Steps Down from Blockchain Association After Regulatory Bill Stalls
Former CFTC commissioner Summer Mersinger resigns as Blockchain Association CEO amid failure of key stablecoin legislation, with interim leadership set for October.
C4 Therapeutics Shows Immune Activation in Multiple Myeloma Trials with Cemsidomide
Biomarker data from Phase 1 trials highlights T-cell activation and safety at tested doses, advancing Phase 1b studies with elranatamab combination.
Core Scientific Names Jay Elms as CCO to Boost AI Data Center Sales
The Miami-based colocation provider expands its commercial leadership with a veteran from data center sales, targeting AI workloads and hyperscale clients.
Ocugen’s Gene Therapy for Retinitis Pigmentosa Advances with Bahamas Approval
Ocugen Inc. secured provisional approval from The Bahamas’ Longevity and Regenerative Therapies Board for its investigational NR2E3-based gene therapy, OCU400, targeting retinitis pigmentosa—marking a key milestone ahead of U.S. and EU regulatory submissions.
Blockchain Association CEO Mersinger Exits After Clarity Act Defeat
Kristin Smith returns as interim CEO of the Blockchain Association one week after the Digital Asset Market Clarity Act was rejected by the Senate.
Canadian Dollar Under Pressure as Rate Gap, Trade Risks Mount
CIBC forecasts the Loonie to weaken toward 1.42 by year-end before recovering on easing trade tensions and a potential Bank of Canada rate hike in early 2027.
IBIT Options Price Calmer Swing Expectations After Bitcoin Rebound
BlackRock's IBIT options show implied volatility near the low end of its 12-month range despite Bitcoin's recent recovery, per Saxo Bank.
CIBC forecasts Canadian dollar near 1.42 USD/CAD in Q4 2026 as rate gap widens
CIBC Capital Markets projects the USD/CAD pair to average 1.42 in Q4 2026, citing a widening interest‑rate gap and trade tensions with the United States, while expecting the Fed to tighten and the BoC to hold rates.
CoreCivic Names Mayberry as CEO After Swindle Resigns Due to Health
CoreCivic, Inc. appointed Lucibeth N. Mayberry as CEO following Patrick D. Swindle’s resignation amid stage-four pancreatic cancer treatment.
Canadian dollar holds near lows as U.S. dollar rally persists
The loonie lingers near multi-week lows at about C$1.4149 against the greenback, weighed by U.S. Treasury yields and weak Canadian retail sales.
Canadian dollar near C$1.4150 as U.S. dollar strength persists
The Canadian dollar remains under pressure near a multi-week low amid a broader U.S. dollar rally and expectations of tighter Federal Reserve monetary policy.
Sellas Reports Preclinical Evidence for CDK9 Inhibitor SLS009 in Pancreatic Cancer
Sellas Life Sciences Group Inc. highlighted encouraging preclinical data for its CDK9 inhibitor SLS009, showing potential synergy with RAS-directed therapies in MYC-amplified pancreatic cancer models.
Bernstein Names Sonova, Alcon Top European Medtech Picks for H2
The firm highlighted Sonova as its short-term top pick and Alcon as the preferred long-term play, citing strong fundamentals in hearing aids and ophthalmology.
Leader's Advantage SPAC raises $150M in Nasdaq IPO
The SPAC completes a $150 million initial public offering on Nasdaq with units priced at $10 each, targeting healthcare, specialty chemicals, and defense sectors.
FMC Stock Hits 52-Week Low at $9.48 Amid Revenue Miss and Demand Headwinds
Ag-chemical maker FMC saw shares fall to $9.48, down 70% over the past year, after Q2 results showed a revenue shortfall driven by weak demand and pricing pressure.
Tether says exposure to EQIBank was limited after $84M seizure
Tether confirmed it holds assets at EQIBank, but those assets represent only 0.034% of its total, after US prosecutors froze about $84 million in accounts of payments firm Capstone linked to the bank. USDT market cap is $184 billion.